References
1. Hashimoto T., Shibasaki F. Hypoxia-Inducible Factor as an angiogenic master switch. Front. Pediatr. 2015; 3: 33.
URL: https://www.ncbi.nlm.nih.gov/pubmed/25964891
doi: 10.3389/fped.2015.00033
2. Ratcliffe P., Koivunen P., Myllyharju J., Ragoussis J., et al. Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics. Hypoxia. 2017; 5: 11-20.
URL: https://www.ncbi.nlm.nih.gov/pubmed/28352643
doi: 10.2147/HP.S127042
3. Chen R., Lai U.H., Zhu L., Singh A., et al. Reactive oxygen species formation in the brain at different oxygen levels: the role of hypoxia inducible factors. Front. Cell Dev. Biol. 2018; 6: 132.
URL: https://www.ncbi.nlm.nih.gov/pubmed/30364203
doi: 10.3389/fcell.2018.00132
4. Koyasu S., Kobayashi M., Goto Y., Hiraoka M., et al. Regulatory mechanisms of hypoxia-inducible factor 1 activity: two decades of knowledge. Cancer Sci. 2018; 109 (3): 560-71.
URL: https://www.ncbi.nlm.nih.gov/pubmed/29285833
doi: 10.1111/cas.13483
5. Watts E.R., Walmsley S.R. Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol. Med. 2019; 25 (1): 33-46.
URL: https://www.ncbi.nlm.nih.gov/pubmed/30442494
doi: 10.1016/j.molmed.2018.10.006
6. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992; 12 (12): 5447-54.
7. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA. 1995; 92 (12): 5510-4.
8. Fratantonio D., Cimino F., Speciale A., Virgili F. Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability. Biofactors. 2018; 44 (3): 207-18.
URL: https://digitalcommons.unl.edu/cgi/viewcontent.cgi?referer=https://www.google.com/&httpsredir=1&article=1159&context=nutritionfacpub
doi: 10.1002/biof.1419
9. Stothers C.L., Luan L., Fensterheim B.A., Bohannon J.K. Hypoxia-inducible factor-1α regulation of myeloid cells. J. Mol. Med. 2018; 96 (12): 1293-306
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292431/
doi: 10.1007/s00109-018-1710-1
10. Ivan M., Kondo K., Yang H., Kim W., et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001; 292 (5516): 464-8.
11. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292 (5516): 468-72.
12. Mahon P.C., Hirota K., Semenza G.L. FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001; 15 (20): 2675-86.
13. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107 (1): 43-54.
14. Frede S., Stockmann C., Freitag P., Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kB. Biochem. J. 2006; 396 (3): 517-27.
15. Schofield C.J., Zhang, Z. Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr. Opin. Struct. Biol. 1999; 9 (6): 722-31.
16. Schodel J., Oikonomopoulos S., Ragoussis J., PughC.W., et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood. 2011; 117 (23): e207-17.
URL: https://www.ncbi.nlm.nih.gov/pubmed/21447827
doi: 10.1182/blood-2010-10-314427
17. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell. 2012; 148 (3): 399-408.
URL: https://www.ncbi.nlm.nih.gov/pubmed/22304911
doi: 10.1016/j.cell.2012.01.021
18. Kletsas D., Pratsinis H., Mariatos G., Zacharatos P., et al. The proinflammatory phenotype of senescent cells: the p53-mediated ICAM-1 expression. Ann. N. Y. Acad. Sci. 2004; 1019: 330-2.
19. Hayden M.S., Ghosh S. NF-kB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012; 26 (3): 203-34.
20. Liu T., Zhang L., Joo D., Sun S.C. NF-kB signaling in inflammation. Signal Transduct. Target. Ther. 2017; 2: e17023.
URL: https://www.ncbi.nlm.nih.gov/pubmed/29158945
doi: 10.1038/sigtrans.2017.23
21. Mitchell S., Vargas J., Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip. Rev. Syst. Biol. Med. 2016; 8 (3): 227-41.
URL: https://www.ncbi.nlm.nih.gov/pubmed/26990581
doi: 10.1002/wsbm.1331
22. Ghosh S., May M.J., Kopp E.B. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 1998; 16: 225-60.
23. Karin M. Nuclear factor-κB in cancer development and progression. Nature. 2006; 441 (7092): 431-6.
24. Sakai J., Cammarota E., Wright J.A., Cicuta P., et al. Lipopolysaccharide-induced NF-κB nuclear translocationis primarily dependent on MyD88, but TNFα expressionrequires TRIF and MyD88. Sci. Rep. 2017; 7 (1): 1428.
URL: https://www.ncbi.nlm.nih.gov/pubmed/28469251
doi: 10.1038/s41598-017-01600-y
25. Hirota K. Involvement of hypoxia-inducible factors in the dysregulation of oxygen homeostasis in sepsis. Cardiovasc. Hematol. Disord. Drug Targets. 2015; 15 (1): 29-40.
26. Kiers H.D., Scheffer G.-J., van der Hoeven J.G., Eltzschig H.K., et al. Immunologic Consequences of hypoxia during critical illness. Anesthesiology. 2016; 125 (1): 237-49.
URL: https://www.ncbi.nlm.nih.gov/pubmed/27183167
doi: 10.1097/ALN.0000000000001163
27. Devraj G., Beerlage C., Brune B., Kempf V.A. Hypoxia and HIF-1 activation in bacterial infections. Microbes Infect. 2017; 19 (3): 144-56.
URL: https://www.ncbi.nlm.nih.gov/pubmed/27903434
doi: 10.1016/j.micinf.2016.11.003
28. Eltzschig H.K., Carmeliet P. Hypoxia and inflammation. N. Engl. J. Med. 2011; 364 (7): 656-65.
29. van der Flier M., Stockhammer G., Vonk G.J., Nikkels P.G., et al. Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J. Infect. Dis. 2001; 183 (1): 149-53.
URL: https://www.ncbi.nlm.nih.gov/pubmed/11106541
doi: 10.1086/317643
30. Riess T., Andersson S.G.E., Lupas A., Schaller M., et al. Bartonella adhesin a mediates a proangiogenic host cell response. J. Exp. Med. 2004; 200 (10): 1267-78.
URL: https://rupress.org/jem/article/200/10/1267/52512/Bartonella-Adhesin-A-Mediates-a-Proangiogenic-Host
doi: 10.1084/jem.20040500
31. Kempf V.A., Lebiedziejewski M., Alitalo K., Walzlein J.H., et al. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation. 2005; 111 (8): 1054-62.
URL: https://www.ncbi.nlm.nih.gov/pubmed/15723970
doi: 10.1161/01.CIR.0000155608.07691.B7
32. Charpentier T., Hammami A., Stager S. Hypoxia inducible factor 1α: a critical factor for the immune response to pathogens and Leishmania. Cell. Immunol. 2016; 309: 42-9.
URL: https://www.sciencedirect.com/science/article/abs/pii/S0008874916300478?via%3Dihub
doi: 10.1016/j.cellimm.2016.06.002
33. Schaffer K., Taylor C.T. The impact of hypoxia on bacterial infection. FEBS J. 2015; 282 (12): 2260-6.
34. Rius J., Guma M., Schachtrup C., Akassoglou K., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008; 453 (7196): 807-11.
URL: https://www.ncbi.nlm.nih.gov/pubmed/18432192
doi: 10.1038/nature06905
35. van Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem. J. 2008; 412 (3): 477-84.
URL: https://www.ncbi.nlm.nih.gov/pubmed/18393939
doi: 10.1042/BJ20080476
36. van Uden P., Kenneth N.S., Webster R., Muller H.A., et al. Evolutionary conserved regulation of HIF-1beta by NF-kappaB. PLoS Genet. 2011; 7 (1): e1001285.
URL: https://www.ncbi.nlm.nih.gov/pubmed/21298084
doi: 10.1371/journal.pgen.1001285
37. Bonello S., Zahringer C., BelAiba R.S., Djordjevic T., et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler. Thromb. Vasc. Biol. 2007; 27 (4): 755-61.
38. BelAiba R.S., Bonello S., Zahringer C., Schmidt S., et al. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol. Biol. Cell. 2007; 18 (12): 4691-7.
URL: https://www.ncbi.nlm.nih.gov/pubmed/17898080
doi: 10.1091/mbc.e07-04-0391
39. Nishi K., Oda T., Takabuchi S., Oda S., et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid. Redox Signal. 2008; 10 (5): 983-95.
URL: https://www.ncbi.nlm.nih.gov/pubmed/18199003
doi: 10.1089/ars.2007.1825
40. Bandarra D., Rocha S. HIF-1α a novel piece in the NF-κB puzzle. Inflamm Cell Signal. 2015; 2: e792.
URL: https://www.researchgate.net/publication/277329952_HIF-1a_a_novel_piece_in_the_NF-kB_puzzle
doi: 10.14800/ics.792
41. Halligan D.N., Murphy S.J.E., Taylor C.T. The hypoxia-inducible factor (HIF) couples immunity with metabolism. Semin. Immunol. 2016; 28 (5): 469-77.
42. Taylor C.T, Colgan S.P. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat. Rev. Immunol. 2017; 17 (12): 774-85.
URL: https://www.ncbi.nlm.nih.gov/pubmed/28972206
doi: 10.1038/nri.2017.103
43. Hellwig-Burgel T., Rutkowski K., Metzen E., Fandrey J., et al. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood. 1999; 94 (5): 1561-7.
44. Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013; 496 (7444): 238-42.
45. Dehne N., Brune B. HIF-1 in the inflammatory microenvironment. Exp. Cell Res. 2009; 315 (11): 1791-7.
46. Jantsch J., Wiese M., Schodel J., Castiglione K., et al. Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1α(HIF1A) and result in differential HIF1A-dependent gene expression. J. Leukoc. Biol. 2011; 90 (3): 551-62.
47. Oliver K.M., Taylor C.T., Cummins E.P. Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases. Arthritis Res. Ther. 2009; 11 (1): 215.
URL: https://www.ncbi.nlm.nih.gov/pubmed/19291263
doi: 10.1186/ar2575
48. Kruger B., Krick S., Dhillon N., Lerner S.M., et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl Acad. Sci. USA. 2009; 106 (9): 3390-5.
49. Ferguson N.D., Fan E., Camporota L., Antonelli M., et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012; 38 (10): 1573-82.
50. Suganami T., Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J. Leukoc. Biol. 2010; 88 (1): 33-9.
51. Wang J.S., Liu H.C. Systemic hypoxia enhances bactericidal activities of human polymorphonuclear leuocytes. Clin. Sci. (Lond.). 2009; 116 (11): 805-17.
URL: https://www.ncbi.nlm.nih.gov/pubmed/19053944
doi: 10.1042/CS20080224
52. Fritzenwanger M., Jung C., Goebel B., Lauten A., et al. Impact of short-term systemic hypoxia on phagocytosis, cytokine production, and transcription factor activation in peripheral blood cells. Mediators Inflamm. 2011; 2011: 429501.
URL: https://www.ncbi.nlm.nih.gov/pubmed/21765619
doi: 10.1155/2011/429501
53. Richard N.A., Sahota I.S., Widmer N., Ferguson S., et al. Acute mountain sickness, chemosensitivity and cardio-respiratory responses in humans exposed to hypobaric and normobaric hypoxia. J. Appl. Physiol. 2014; 116 (7): 945-52.
54. Grocott M., Montgomery H., Vercueil A. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit. Care. 2007; 11 (1): 203.
55. Hartmann G., Tschop M., Fischer R., Bidlingmaier C., et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine. 2000; 12 (3): 246-52.
56. Cummins E.P., Berra E., Comerford K.M., Ginouves A., et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl Acad. Sci. USA. 2006; 103 (48): 18 154-9.
57. Cockman M.E., Lancaster D.E., Stolze I.P., Hewitson K.S., et al. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl Acad. Sci. USA. 2006; 103: 14 767-72.
58. Dzhalilova D.Sh., Kosyreva A.M., Diatroptov M.E., Ponomarenko E.A., et al. Dependence of the severity of the systemic inflammatory response on resistance to hypoxia in male Wistar rats. J Inflamm Res. 2019; 12: 73-86.
59. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alphadependent NF-kappaB activity. J. Exp. Med. 2005; 201 (1): 105-15.
60. Peyssonnaux C., Datta V., Cramer T., Doedens A., et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 2005; 115: 1806-15.
61. Ben-Shoshan J., Afek A., Maysel-Auslender S., Barzelay A., et al. HIF-1alpha overexpression and experimental murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009; 29 (5): 665-70.
URL: https://www.ncbi.nlm.nih.gov/pubmed/19251587
doi: 10.1161/ATVBAHA.108.183319
62. Clambey E.T., McNamee E.N., Westrich J.A., Glover L.E., et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl Acad. Sci. USA. 2012; 109 (41): E2784-93.
URL: https://www.ncbi.nlm.nih.gov/pubmed/22988108
doi: 10.1073/pnas.1202366109
63. Campbell E.L., Bruyninckx W.J., Kelly C.J., Glover L.E., et al. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation.Immunity. 2014; 40 (1): 66-77.
URL: https://www.ncbi.nlm.nih.gov/pubmed/24412613
doi: 10.1016/j.immuni.2013.11.020
64. Barbi J., Pardoll D., Pan F. Metabolic control of the Treg/Th17 axis. Immunol. Rev. 2013; 252 (1): 52-77.
URL: https://www.ncbi.nlm.nih.gov/pubmed/23405895
doi: 10.1111/imr.12029
65. Sadiku P., Walmsley S.R. Hypoxia and the regulation of myeloid cell metabolic imprinting: consequences for the inflammatory response. EMBO Rep. 2019; 20 (5): e47388.
URL: https://www.ncbi.nlm.nih.gov/pubmed/30872317
doi: 10.15252/embr.201847388
66. Thompson A.A., Binham J., Plant T., Whyte M.K., et al. Hypoxia, the HIF pathway and neutrophilic inflammatory responses. Biol. Chem. 2013; 394 (4): 471-7.
67. Krzywinska E., Stockmann C. Hypoxia, metabolism and immune cell function. Biomedicines. 2018; 6 (2): E56.
URL: https://www.ncbi.nlm.nih.gov/pubmed/29762526
doi: 10.3390/biomedicines6020056
68. Kojima H., Jones B.T., Chen J., Cascalho M., et al.Hypoxia-inducible factor 1alpha-deficient chimeric mice as a model to study abnormal B lymphocyte development and autoimmunity. Methods Enzymol. 2004; 381: 218-29.
69. Hartmann H., Eltzschig H.K., Wurz H., Hantke K., et al. Hypoxia-independent activation of HIF-1 by Enterobacteriaceae and their siderophores. Gastroenterology. 2008; 134 (3): 756-67.
URL: https://www.ncbi.nlm.nih.gov/pubmed/18325389
doi: 10.1053/j.gastro.2007.12.008
70. Karhausen J., Furuta G.T., Tomaszewski J.E., Johnson R.S., et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 2004; 114 (8): 1098-106.
71. Manresa M.C., Taylor C.T. Hypoxia inducible factor (HIF) hydroxylases as regulators of intestinal epithelial barrier function. Cell. Mol. Gastroenterol. Hepatol. 2017; 3: 303-15.
72. Sun M., He C., Wu W., Zhou G., et al. Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributesto mucosal homeostasis in inflammatory bowel disease. Clin. Exp. Immunol. 2017; 187 (3): 428-40.
URL: https://www.ncbi.nlm.nih.gov/pubmed/27921309
doi: 10.1111/cei.12896
73. Robinson A., Keely S., Karhausen J., Gerich M.E., et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology. 2008; 134: 145-55.
74. Triner D., Shah Y.M. Hypoxia-inducible factors: a central link between inflammation and cancer. J. Clin. Invest. 2016; 126 (10): 3689-98.
URL: https://www.ncbi.nlm.nih.gov/pubmed/27525434
doi: 10.1172/JCI84430
75. Hirota S.A., Fines K., Ng J., Traboulsi D., et al. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology. 2010; 139 (1): 259-69.e3.
URL: https://www.ncbi.nlm.nih.gov/pubmed/20347817
doi: 10.1053/j.gastro.2010.03.045
76. Peyssonnaux C., Boutin A.T., Zinkernagel A.S., Datta V., et al. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J. Invest. Dermatol. 2008; 128 (8): 1964-8.
77. Schaible B., McClean S., Selfridge A., Broquet A., et al. Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS One. 2013; 8 (2): e56491.
URL: https://www.ncbi.nlm.nih.gov/pubmed/23418576
doi: 10.1371/journal.pone.0056491
78. Peyssonnaux C., Cejudo-Martin P., Doedens A., Zinkernagel A.S., et al. Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J. Immunol. 2007; 178 (12): 7516-9.
79. Werth N., Beerlage C., Rosenberger C., Yazdi A.S., et al. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One. 2010; 5 (7): e11576.
URL: https://www.ncbi.nlm.nih.gov/pubmed/20644645
doi: 10.1371/journal.pone.0011576
80. Mahabeleshwar G.H., Qureshi M.A., Takami Y., Sharma N., et al. A myeloid hypoxia- inducible factor 1a-Kruppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis. J. Biol. Chem. 2012; 287: 1448-57.
81. Ono S., Tsujimoto H., Hiraki S., Aosasa S. Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis. Ann. Gastroenterol. Surg. 2018; 2 (5): 351-8.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139715/
doi: 10.1002/ags3.12194
82. Textoris J., Beaufils N., Quintana G., Ben Lassoued A., et al. Hypoxia-inducible factor (HIF1a) gene expression in human shock states. Crit. Care. 2012; 16 (4): R120.
URL: https://www.ncbi.nlm.nih.gov/pubmed/22781303
doi: 10.1186/cc11414
83. Pan H., Wu X. Hypoxia attenuates inflammatory mediators production induced by Acanthamoeba via Toll-like receptor 4 signaling in human corneal epithelial cells. Biochem. Biophys. Res. Commun. 2012; 420 (3): 685-91.
84. Kiers H.D., Scheffer G.-J., van der Hoeven J.G., Eltzschig H.K., et al. Immunologic consequences of hypoxia during critical illness. Anesthesiology. 2016; 125 (1): 237-49.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119461/
doi: 10.1097/ALN.0000000000001163